Forte Biosciences, Inc.FBRXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-39.15%
↓ 86% vs avg
Percentile
P24
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-21.06%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -39.15% |
| Q2 2025 | 2.84% |
| Q1 2025 | -3.46% |
| Q4 2024 | -23.07% |
| Q3 2024 | -37.01% |
| Q2 2024 | 10.96% |
| Q1 2024 | 25.67% |
| Q4 2023 | 0.98% |
| Q3 2023 | -65.44% |
| Q2 2023 | -5.21% |
| Q1 2023 | -79.88% |
| Q4 2022 | -49.12% |
| Q3 2022 | -40.89% |
| Q2 2022 | 30.28% |
| Q1 2022 | 44.86% |
| Q4 2021 | 30.13% |
| Q3 2021 | -30.19% |
| Q2 2021 | 2.28% |
| Q1 2021 | -5.97% |
| Q4 2020 | 50.86% |
| Q3 2020 | -92.70% |
| Q2 2020 | -40.17% |
| Q1 2020 | -338.74% |
| Q4 2019 | -18.08% |
| Q3 2019 | 53.53% |
| Q2 2019 | -217.33% |
| Q1 2019 | 96.93% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |